Massive study probes heart risks of popular Weight-Loss pill
Disease control
Recruiting now
This large study aims to find out if a weight loss medication (Contrave/Mysimba) increases the risk of serious heart problems like heart attacks or strokes. It will enroll 8,600 overweight or obese adults who already have a higher risk for heart disease. Participants will be rand…
Phase: PHASE4 • Sponsor: Currax Pharmaceuticals • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC